Serum biomarkers of oxidative stress in cats with feline infectious peritonitis

Research in Veterinary Science

Volumn 100, Issue , 2015, Pages 12-17

  Tecles, F ^a   Caldin M ^b   Tvarijonaviciute, A ^a   Escribano, D ^a   Martinez Subiela S ^a   Ceron J J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b San Marco Veterinary Clinic   (Italy)

Author keywords

Cat; Feline infectious peritonitis; Inflammation; Oxidative stress; Paraoxonase; Total antioxidant capacity

Indexed keywords

4 NITROPHENYLACETATE; 5 THIOBUTILBUTYROLACTONE; ARYLDIALKYLPHOSPHATASE 1; BUTYROLACTONE; PHENYLACETIC ACID; PHENYLACETIC ACID DERIVATIVE; SERUM AMYLOID A; UNCLASSIFIED DRUG; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER;

ARTICLE; CAT; CONTROLLED STUDY; FELINE CORONAVIRUS; FELINE IMMUNODEFICIENCY VIRUS; FELINE INFECTIOUS PERITONITIS; HEMATOLOGICAL PARAMETERS; LIMIT OF DETECTION; NONHUMAN; OXIDATIVE STRESS; RETROSPECTIVE STUDY; TOTAL ANTIOXIDANT CAPACITY; ANIMAL; BLOOD; BLOOD ANALYSIS; PHYSIOLOGY; SPECTROPHOTOMETRY; VETERINARY; VIROLOGY;

FELIDAE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; CATS; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY;

EID: 84930930778     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2015.02.007     Document Type: Article

References (44)

1. Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C., et al. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metabolism and Disposition 2000, 28:1335-1342.
2. Bionaz M., Trevisi E., Calamari L., Librandi F., Ferrai A., Bertoni G. Plasma paraoxonase, health, inflammatory conditions, and liver function in transition dairy cows. Journal of Dairy Science 2007, 90:1740-1750.
3. Camps J., Marsillach J., Joven J. The paraoxonase: role in human diseases and methodological difficulties in measurement. Critical Reviews in Clinical Laboratory Science 2009, 46:83-106.
4. Ceron J.J., Tecles F., Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. BMC Veterinary Research 2014, 10:74. 10.1186/1746-6148-10-74.
5. Christopher M.M., Broussard J.D., Peterson M.E. Heinz body formation associated with ketoacidosis in diabetic cats. Journal of Veterinary Internal Medicine 1995, 9:24-31.
6. Chun C.K., Ozer E.A., Welsh M.J., Zabner J., Greenberg E.P. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3587-3590.
7. Dantoine T.F., Debord J., Charmes J.P., Merle L., Marquet P., Lachatre G., et al. Decrease of serum paraoxonase activity in chronic renal failure. Journal of the American Society of Nephrology 1998, 9:2082-2088.
8. Delmas-Beauvieux M.C., Peuchant E., Couchouron A., Constans J., Sergeant C., Simonoff M., et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. The American Journal of Clinical Nutrition 1996, 64:101-107.
9. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Chemistry 2004, 37:277-285.
10. Farid A.S., Horii Y. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis. Lipids in Health and Disease 2012, 11:92.
11. Feingold K.R., Memon R.A., Moser A.H., Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998, 139:307-315.
12. Franco-Pons N., Marsillach J., Joven J., Camps J., Closa D. Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis. Journal of Gastrointestinal Surgery 2008, 12:891-899.
13. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radical Biology and Medicine 2000, 29:1106-1114.
14. Giordano A., Spagnolo V., Colom A., Paltrinieri S. Changes in some acute phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection. The Veterinary Journal 2004, 167:38-44.
15. Guidance for Industry: Bioanalytical Method Validation, US accessed 20.11.10. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
16. Gunn-Moore D.A., Caney S.M., Gruffydd-Jones T.J., Helps C.R., Harbour D.A. Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP). Veterinary Immunology and Immunopathology 1998, 65:221-242.
17. Harvey J.W., Kaneko J.J. Mammalian erythrocyte metabolism and oxidant drugs. Toxicology and Applied Pharmacology 1977, 42:253-261.
18. James R.W. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clinical Chemistry and Laboratory Medicine 2007, 44:1052-1059.
19. Kajikawa T., Furuta A., Onishi T., Tajima T., Sugii S. Changes in concentrations of serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Veterinary Immunology and Immunopathology 1999, 68:91-98.
20. Kappelle P.J., Bijzet J., Hazenberg B.P., Dullaart R.P. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome. Archives of Medical Research 2011, 42:219-225.
21. Keegan R.F., Webb C.B. Oxidative stress and neutrophil function in cats with chronic renal failure. Journal of Veterinary Internal Medicine 2010, 24:514-519.
22. Keskin M., Dolar E., Dirican M., Kiyici M., Yilmaz Y., Gurel S., et al. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity. Internal Medicine Journal 2009, 39:243-248.
23. Licitra B.N., Millet J.K., Regan A.D., Hamilton B.S., Rinaldi V.D., Duhamel G.E., et al. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerging Infectious Diseases 2013, 19:1066-1073.
24. Marsillach J., Aragonès G., Beltrán R., Caballeria J., Pedro-Botet J., Morcillo-Suárez C., et al. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clinical Biochemistry 2009, 42:91-98.
25. Mogarekar M.R., Chawhan S.S. The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenyl acetate. Indian Journal of Human Genetics 2013, 19:71-77.
26. Montorfano I., Becerra A., Cerro R., Echeverría C., Sáez E., Morales M.G., et al. Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway. Laboratory Investigation; a journal of technical methods and pathology 2014, 94:1068-1082.
27. Nagy G., Ward J., Mosser D.D., Koncz A., Gergely P., Stancato C., et al. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. The Journal of Biological Chemistry 2006, 281:34574-34591.
28. Novak F., Vavrova L., Kodydkova J., Novak F., Hynkova M., Zak A., et al. Decreased paraoxonase activity in critically ill patients with sepsis. Clinical and Experimental Medicine 2010, 10:21-25.
29. Paracha U.Z., Fatima K., Alqahtani M., Chaudhary A., Abuzenadah A., Damanhouri G., et al. Oxidative stress and hepatitis C virus. Virology Journal 2013, 10:251.
30. Parra S., Alonso-Villaverde C., Coll B., Ferré N., Marsillach J., Aragonés G., et al. Serum paraoxonase 1 activity and concentration are influenced by human immunodeficiency virus infection. Atheroesclerosis 2007, 194:175-181.
31. Parra S., Marsillach J., Aragonés G., Rull A., Beltrán-Debón R., Alonso-Villaverde C., et al. Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients. Lipids in Health and Disease 2010, 9:32.
32. Pedersen N.C. An update on feline infectious peritonitis: virology and immunopathogenesis. The Veterinary Journal 2014, 201:123-132.
33. Pedersen N.C. An update on feline infectious peritonitis: diagnostic and therapeutics. The Veterinary Journal 2014, 201:133-141.
34. Regan A.D., Cohen R.D., Whittaker G.R. Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells. Virology 2009, 384:135-143.
35. Suresh D.R., Annam V., Pratibha K., Prasad B.V. Total antioxidant capacity - a novel early bio-chemical marker of oxidative stress in HIV infected individuals. Journal of Biomedical Science 2009, 16:61.
36. Treitinger A., Spada C., Verdi J.C., Miranda A.F., Oliveira O.V., Silveira M.V., et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. European Journal of Clinical Investigation 2000, 30:454-459.
37. Turk R., Habuš J., Flegar-Meštrić Z., Svetina A., Mojčec V., Perkov S., et al. Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp. Acta Tropica 2011, 118:97-100.
38. Tvarijonaviciute A., Kocaturk M., Cansev M., Tecles F., Cerón J.J. Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: effects of choline administration. Research in Veterinary Science 2012, 93:668-674.
39. Tvarijonaviciute A., Tecles F., Caldin M., Tasca S., Cerón J. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. American Journal of Veterinary Research 2012, 73:34-41.
40. Tvarijonaviciute A., Cerón J.J., Holden S.L., Morris P.J., Biourge V., German A.J. Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Domestic Animal Endocrinology 2012, 42:129-141.
41. van Himbergen T.M., Roest M., Graaf J., Jansen E.H., Hattori H., Kastelein J.J., et al. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. Journal of Lipid Research 2005, 46:445-451.
42. Webb C., Lehman T., McCord K., Avery P., Dow S. Oxidative stress during acute FIV infection in cats. Veterinary Immunology and Immunopathology 2008, 122:16-24.
43. Webb C.B., Falkowski L. Oxidative stress and innate immunity in feline patients with diabetes mellitus: the role of nutrition. Journal of Feline Medicine and Surgery 2009, 11:271-276.
44. Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Archives of Medical Science 2012, 1:138-153.